Why ImmunityBio Inc. (IBRX) Went Up Last Week?

We recently published a list of 10 Stocks Outperform Broader Market Last Week. In this article, we are going to take a look at where ImmunityBio Inc. (NASDAQ:IBRX) stands against other stocks that outperformed broader market last week.

Wall Street’s main indices traded lower week-on-week as investor sentiment continued to be dragged by the ongoing trade tensions globally.

The tech-heavy Nasdaq was down by 2.59 percent versus its level on March 21. Meanwhile, the S&P 500 declined by 1.5 percent and the Dow Jones dropped by 0.956 percent.

Ten individual stocks, on the other hand, managed to stay stronger, three of which were particularly notable as funds flocking to gold assets spilled over into their stocks.

In this article, we listed last week’s 10 top performers and detailed the reasons behind their gains.

To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5 million trading volume.

A technician analyzing natural killer cells, as part of an immune system study and research into therapeutical agents.

ImmunityBio Inc. (NASDAQ:IBRX)

Despite a 6.55 percent drop in Friday’s trading, ImmunityBio managed to finish stronger week-on-week, adding 15.9 percent to its valuation at $3.14 versus the $2.71 registered on March 21.

Trading in the company was particularly influenced by its upcoming Investor Day, slated for April 15, 2025, where it is expected to announce in-depth updates about its business operations and recent research and development advancements.

According to the company, key timelines for catalysts of product candidates will be presented, along with a discussion of ongoing clinical trials.

“ImmunityBio commenced 2025 with notable scientific and business milestones. With a promising future ahead, we are eager to engage with our investors and share the reasons we’re optimistic and excited about the company’s growth trajectory,” said IBRX President and CEO Richard Adcock.

Overall, IBRX ranks 3rd on our list of stocks that outperformed broader market last week. While we acknowledge the potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is as promising as IBRX but trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.